Vimta Labs
add_icon

Vimta Labs

439.45
-2.65
(-0.60%)
Market Cap
1,961.49 Cr
PE Ratio
32.22
Volume
1,12,655.00
Day High - Low
444.80 - 432.60
52W High-Low
902.65 - 400.30
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,961.49 Cr
EPS
18.51
PE Ratio
32.22
PB Ratio
5.77
Book Value
93.22
EBITDA
90.80
Dividend Yield
0.23 %
Industry
Healthcare
Return on Equity
12.83
Debt to Equity
0.06
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Vimta Labs Limited allotted 34,166 employee stock options under its ESOP Plan 2021, increasing paid-up share capital from ₹8,92,70,378 to ₹8,93,38,710 with shares ranking pari-passu.
positive
VIMTA Labs reported a net profit of ₹176 million for Q3, marking a marginal increase from ₹175 million in the corresponding quarter of the previous year, representing steady performance.
neutral
Vimta Labs Limited announces investor conference call scheduled for January 28, 2026 at 4:30 PM IST to discuss Q3FY26 financial results, with senior management participation.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
404.10
#1 16,282.78
46.62
#1 3,714.20
3.77
#1 496
-88.56
26.23
443.45
10,656.86
#1 24.62
2,946.50
10.53
407
-6.20
30.57
136.72
3,110.03
-13.55
17.60
-46.34
-161
-160.61
40.26
439.45
#4 1,961.49
#2 32.22
#4 322.30
#7 0.22
#3 41
#2 112.87
40.54
41.71
617.03
361.18
10.20
#1 126.67
1
-97.69
50.43
58.43
137.56
-3.30
806.50
4.78
-56
20.99
39.68
60.23
119.97
-59.62
47.50
17.87
0
#1 2,300.00
35.69
17.58
25.40
33.09
84.00
5.00
2
-83.33
26.12
18.50
13.16
-1.04
2.10
-78.57
-13
-450.00
44.34

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
0.22 %
Net Income Growth
-14.94 %
Cash Flow Change
-30.76 %
ROE
-24.97 %
ROCE
-26.21 %
EBITDA Margin (Avg.)
-7.88 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
45
33
59
59
60
62
76
68
75
80
81
79
83
84
68
75
80
76
85
95
Expenses
38
29
43
42
43
45
57
47
51
55
55
56
58
59
50
53
55
51
57
57
EBITDA
7
4
16
17
17
17
19
21
24
25
26
23
25
25
18
23
25
25
29
38
Operating Profit %
11 %
11 %
27 %
28 %
28 %
27 %
25 %
31 %
31 %
30 %
32 %
28 %
30 %
30 %
24 %
29 %
31 %
32 %
33 %
37 %
Depreciation
5
6
6
6
6
6
6
6
7
7
8
8
8
9
9
8
8
8
8
10
Interest
1
1
0
1
1
0
0
0
1
1
1
1
0
0
1
1
1
1
0
1
Profit Before Tax
0
-2
0
11
10
11
13
16
16
17
18
14
17
16
8
14
16
17
20
28
Tax
0
-1
-8
3
3
3
3
4
4
5
5
4
4
4
2
3
4
4
5
6
Net Profit
0
-2
8
8
8
8
10
12
12
12
13
10
13
12
6
10
12
12
15
22
EPS in ₹
0.03
-0.88
3.41
3.65
3.50
3.65
4.41
5.28
5.36
5.45
5.97
4.62
5.73
5.51
2.86
3.61
5.58
5.54
6.88
9.65

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
246
274
307
362
400
Fixed Assets
138
135
169
175
171
Current Assets
96
111
124
164
158
Capital Work in Progress
2
18
0
12
59
Investments
0
0
0
0
0
Other Assets
106
122
138
175
170
Total Equity & Liabilities
246
274
307
362
400
Current Liabilities
58
54
48
57
54
Non Current Liabilities
15
26
26
23
26
Total Equity
173
194
234
282
320
Reserve & Surplus
169
190
230
277
315
Share Capital
4
4
4
4
4

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
3
1
5
20
-17
Investing Activities
-21
-32
-38
-57
-76
Operating Activities
24
37
59
88
61
Financing Activities
-1
-5
-17
-11
-2

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
37.46 %
37.46 %
37.46 %
37.46 %
37.46 %
37.46 %
37.46 %
37.25 %
37.24 %
37.23 %
37.01 %
36.98 %
36.92 %
36.89 %
36.89 %
36.76 %
36.70 %
36.67 %
35.99 %
35.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.74 %
0.00 %
5.13 %
5.16 %
3.31 %
3.81 %
3.66 %
3.49 %
4.33 %
4.59 %
DIIs
0.00 %
0.00 %
1.29 %
1.48 %
1.48 %
1.48 %
1.48 %
2.13 %
2.14 %
2.13 %
1.50 %
1.49 %
1.50 %
1.49 %
0.00 %
1.16 %
1.43 %
1.42 %
0.87 %
0.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.08 %
29.45 %
28.48 %
27.35 %
27.07 %
26.99 %
26.79 %
25.06 %
25.19 %
24.60 %
25.00 %
25.15 %
23.08 %
23.13 %
26.53 %
25.09 %
25.17 %
24.02 %
24.62 %
25.12 %
Others
33.46 %
33.09 %
32.77 %
33.71 %
34.00 %
34.07 %
34.27 %
35.56 %
35.43 %
36.04 %
33.75 %
36.38 %
33.37 %
33.33 %
33.27 %
33.18 %
33.03 %
34.40 %
34.18 %
34.29 %
No of Share Holders
12,152
20,928
19,947
19,194
18,332
18,106
18,283
18,916
17,162
17,439
18,429
19,957
18,550
19,054
20,114
21,156
26,183
29,867
55,933
54,467

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 2 2 0.00 2 2 2 2 2 0.00
Dividend Yield (%) 0.00 2.01 6.7 0.00 1.27 1.27 0.9 0.4 0.45 0.00

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 23, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 28, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2026
Q3 FY- 2025-26 - Unaudited Financial ResultsJan 28, 2026
Board Meeting Outcome for Q3 FY- 2025-26 - Unaudited Financial Results.Jan 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 21, 2026
Board Meeting Intimation for Considering The Financial Results For The Quarter Ended 31St December 2025.Jan 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Closure of Trading WindowDec 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 24, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsNov 21, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 03, 2025
Q2 FY- 2025-26 - Unaudited Financial Results.Nov 03, 2025
Board Meeting Outcome for Q2 FY- 2025-26 - Unaudited Financial ResultsNov 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2025
Board Meeting Intimation for Q2 FY2025-26- Financial Results - Board MeetingOct 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Closure of Trading WindowSep 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 08, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 04, 2025
Clarification On Volume MovementSep 03, 2025
Clarification sought from Vimta Labs LtdSep 03, 2025
Update On In-Principle Approval Received From Stock ExchangesSep 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 09, 2025
Announcement under Regulation 30 (LODR)-Credit RatingAug 08, 2025
Clarification On Movement In PriceJul 30, 2025
Clarification sought from Vimta Labs LtdJul 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 21, 2025
Clarification On Volume MovementJul 21, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.05%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
41.40
ATR(14)
Volatile
21.03
STOCH(9,6)
Neutral
29.99
STOCH RSI(14)
Neutral
42.95
MACD(12,26)
Bullish
0.80
ADX(14)
Weak Trend
14.83
UO(9)
Bearish
49.91
ROC(12)
Downtrend But Slowing Down
-5.80
WillR(14)
Neutral
-64.42